Table 1.

Composition of the multi-peptide vaccine.

Peptides are listed alongside their sequence, identifier of the core protein, molecular mass and position of the peptide in the respective corresponding source protein and HLA-restrictions of the peptides. Characterization of the patient’s tumor, HLA ligandome analysis (LC-MS/MS) as well as whole transcriptome sequencing (WTS) of two tumor manifestations (L06/10 – primary tumor; P03/13 lung metastasis) are shown with respective FPKM values (fragments per kilobase mapped) for the transcripts of interest. AA (amino acid); RGS (regulator of G-protein signaling); ADFP (adipose differentiation-related protein/Perlipin); CCND (cyclin D); IGFBP (Insulin-like growth factor-binding protein); MMP (matrix metalloproteinase); MS² (tandem mass spectrometry); Ref. (References).